113 related articles for article (PubMed ID: 21141074)
1. [Therapeutic effect of the low molecular weight inhibitor of the NF-kappaB signaling pathway on experimental autoimmune uveoretinitis].
Keino H
Nippon Ganka Gakkai Zasshi; 2010 Nov; 114(11):944-54. PubMed ID: 21141074
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of the potent IL-12/IL-23 inhibitor STA-5326 on experimental autoimmune uveoretinitis.
Keino H; Watanabe T; Sato Y; Niikura M; Wada Y; Okada AA
Arthritis Res Ther; 2008; 10(5):R122. PubMed ID: 18847496
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-kappaB (NF-kappaB), pyrrolidine dithiocarbamate.
Kitamei H; Iwabuchi K; Namba K; Yoshida K; Yanagawa Y; Kitaichi N; Kitamura M; Ohno S; Onoé K
J Leukoc Biol; 2006 Jun; 79(6):1193-201. PubMed ID: 16574770
[TBL] [Abstract][Full Text] [Related]
4. Caffeic acid phenethyl ester lessens disease symptoms in an experimental autoimmune uveoretinitis mouse model.
Choi JH; Roh KH; Oh H; Park SJ; Ha SM; Kang MS; Lee JH; Jung SY; Song H; Yang JW; Park S
Exp Eye Res; 2015 May; 134():53-62. PubMed ID: 25795054
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of experimental autoimmune uveoretinitis in mice by IKKβ inhibitor IMD-0354.
Liu Y; Kitaichi N; Wu D; Hase K; Satoh M; Iwata D; Namba K; Kanda A; Noda K; Itai A; Iwabuchi K; Ishida S
Biochem Biophys Res Commun; 2020 May; 525(3):589-594. PubMed ID: 32115150
[TBL] [Abstract][Full Text] [Related]
6. Chitosan Oligosaccharides Suppress Nuclear Factor-Kappa B Activation and Ameliorate Experimental Autoimmune Uveoretinitis in Mice.
Hsu SM; Yang CH; Tsai HY; Lin CJ; Fang YH; Shieh CC; Chen SH
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171990
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of experimental autoimmune uveoretinitis with nuclear factor-{kappa}B Inhibitor dehydroxy methyl epoxyquinomicin in mice.
Iwata D; Kitaichi N; Miyazaki A; Iwabuchi K; Yoshida K; Namba K; Ozaki M; Ohno S; Umezawa K; Yamashita K; Todo S; Ishida S; Onoé K
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2077-84. PubMed ID: 19907030
[TBL] [Abstract][Full Text] [Related]
8. Vorinostat Modulates the Imbalance of T Cell Subsets, Suppresses Macrophage Activity, and Ameliorates Experimental Autoimmune Uveoretinitis.
Fang S; Meng X; Zhang Z; Wang Y; Liu Y; You C; Yan H
Neuromolecular Med; 2016 Mar; 18(1):134-45. PubMed ID: 26798022
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde-derived advanced glycation end-product formation.
Dong Z; Iwata D; Kitaichi N; Takeuchi M; Sato M; Endo N; Iwabuchi K; Ando R; Fukuhara J; Kinoshita S; Lennikov A; Kitamura M; Mizuuchi K; Kanda A; Noda K; Namba K; Yamagishi S; Ohno S; Ishida S
J Leukoc Biol; 2014 Dec; 96(6):1077-85. PubMed ID: 25201803
[TBL] [Abstract][Full Text] [Related]
10. Selective abrogation of Th1 response by STA-5326, a potent IL-12/IL-23 inhibitor.
Wada Y; Lu R; Zhou D; Chu J; Przewloka T; Zhang S; Li L; Wu Y; Qin J; Balasubramanyam V; Barsoum J; Ono M
Blood; 2007 Feb; 109(3):1156-64. PubMed ID: 17053051
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of retinoic acid receptor-alpha/beta-specific ligand Am80 suppresses experimental autoimmune uveoretinitis.
Keino H; Watanabe T; Sato Y; Okada AA
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1548-56. PubMed ID: 20861477
[TBL] [Abstract][Full Text] [Related]
12. Suppression of the Reactive Oxygen Response Alleviates Experimental Autoimmune Uveitis in Mice.
Hsu SM; Yang CH; Teng YT; Tsai HY; Lin CY; Lin CJ; Shieh CC; Chen SH
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380695
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide-primed heterotolerant dendritic cells suppress experimental autoimmune uveoretinitis by multiple mechanisms.
Klaska IP; Muckersie E; Martin-Granados C; Christofi M; Forrester JV
Immunology; 2017 Mar; 150(3):364-377. PubMed ID: 27859049
[TBL] [Abstract][Full Text] [Related]
14. Galectin-3 regulates microglial activation and promotes inflammation through TLR4/MyD88/NF-kB in experimental autoimmune uveitis.
Liu Y; Zhao C; Meng J; Li N; Xu Z; Liu X; Hou S
Clin Immunol; 2022 Mar; 236():108939. PubMed ID: 35121106
[TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibitor bortezomib suppresses nuclear factor-kappa B activation and ameliorates eye inflammation in experimental autoimmune uveitis.
Hsu SM; Yang CH; Shen FH; Chen SH; Lin CJ; Shieh CC
Mediators Inflamm; 2015; 2015():847373. PubMed ID: 25653480
[TBL] [Abstract][Full Text] [Related]
16. A cell-permeable peptide inhibitor of p55PIK signaling alleviates ocular inflammation in mouse models of uveitis.
Zhu M; Yang H; Chen Z; Xia X; Deng Q; Shen Y
Exp Eye Res; 2020 Oct; 199():108180. PubMed ID: 32777209
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effect of retinoic acid on experimental autoimmune uveoretinitis.
Keino H; Watanabe T; Sato Y; Okada AA
Br J Ophthalmol; 2010 Jun; 94(6):802-7. PubMed ID: 19965837
[TBL] [Abstract][Full Text] [Related]
18. [Effects of leflunomide on experimental autoimmune uveitis in Lewis rats].
Fang C; Zhou D; Zhan S; He Y; Lin Z; Huang C; Li J
Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):754-61. PubMed ID: 26693771
[TBL] [Abstract][Full Text] [Related]
19. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
[TBL] [Abstract][Full Text] [Related]
20. Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate.
Sakai T; Kohno H; Ishihara T; Higaki M; Saito S; Matsushima M; Mizushima Y; Kitahara K
Exp Eye Res; 2006 Apr; 82(4):657-63. PubMed ID: 16360654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
